The transcriptional activities and cellular localization of the human estrogen receptor alpha are affected by the synonymous Ala87 mutation

Journal of Steroid Biochemistry and Molecular Biology

Volumn 143, Issue , 2014, Pages 99-104

  Fernández Calero, Tamara ^a,b   Astrada, Soledad ^b   Alberti, Álvaro ^b   Horjales, Sofía ^a   Arnal, Jean Francois ^c   Rovira, Carlos ^d   Bollati Fogolín, Mariela ^b   Flouriot, Gilles ^e   Marin, Mónica ^a  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

^c INSERM   (France)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Ala87 polymorphism; Estrogen; Estrogen receptor alpha; Synonymous mutations

Indexed keywords

ALANINE; ESTROGEN RECEPTOR ALPHA; ESTROGEN; ESTROGEN RECEPTOR ALPHA, HUMAN; MESSENGER RNA; PROTEIN BINDING; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL TYPE; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; DNA RESPONSIVE ELEMENT; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MUTATION; POPULATION; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSIENT TRANSFECTION; WESTERN BLOTTING; WILD TYPE; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HELA CELL LINE; HEPG2 CELL LINE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOTTING, WESTERN; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HELA CELLS; HEP G2 CELLS; HUMANS; MUTATION; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84896372285     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.02.016     Document Type: Article

References (41)

1. A. Protzel, and A.J. Morris Gel chromatographic analysis of nascent globin chains. Evidence of nonuniform size distribution J. Biol. Chem. 249 14 1974 4594 4600
2. M. Marin Folding at the rhythm of the rare codon beat Biotechnol. J. 3 8 2008 1047 1057
3. T. Ikemura Codon usage and tRNA content in unicellular and multicellular organisms Mol. Biol. Evol. 2 1 1985 13 34 (Pubitemid 15152046)
4. S. Kanaya et al. Codon usage and tRNA genes in eukaryotes: correlation of codon usage diversity with translation efficiency and with CG-dinucleotide usage as assessed by multivariate analysis J. Mol. Evol. 53 4-5 2001 290 298 (Pubitemid 32889537)
5. S. Kanaya et al. Studies of codon usage and tRNA genes of 18 unicellular organisms and quantification of Bacillus subtilis tRNAs: gene expression level and species-specific diversity of codon usage based on multivariate analysis Gene 238 1 1999 143 155 (Pubitemid 29436104)
6. L. Duret, and D. Mouchiroud Expression pattern and, surprisingly, gene length shape codon usage in Caenorhabditis, Drosophila, and Arabidopsis Proc. Nat. Acad. Sci. U.S.A. 96 8 1999 4482 4487 (Pubitemid 29190362)
7. R.M. Goetz, and A. Fuglsang Correlation of codon bias measures with mRNA levels: analysis of transcriptome data from Escherichia coli Biochem. Biophys. Res. Commun. 327 1 2005 4 7 (Pubitemid 40051343)
8. P. Cortazzo et al. Silent mutations affect in vivo protein folding in Escherichia coli Biochem. Biophys. Res. Commun. 293 1 2002 537 541 (Pubitemid 34694241)
9. A.A. Komar, T. Lesnik, and C. Reiss Synonymous codon substitutions affect ribosome traffic and protein folding during in vitro translation FEBS Lett. 462 3 1999 387 391
10. G.L. Rosano, and E.A. Ceccarelli Rare codon content affects the solubility of recombinant proteins in a codon bias-adjusted Escherichia coli strain Microb. Cell Fact. 8 2009 41
11. G. Lamolle, M. Marin, and F. Alvarez-Valin Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers Mutat. Res. 600 1-2 2006 102 112 (Pubitemid 44255828)
12. C. Kimchi-Sarfaty et al. A silent polymorphism in the MDR1 gene changes substrate specificity Science 315 5811 2007 525 528 (Pubitemid 46175758)
13. T. Garcia et al. A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors Mol. Endocrinol. 2 9 1988 785 791
14. L. Gennari et al. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review Am. J. Epidemiol. 161 4 2005 307 320 (Pubitemid 40256202)
15. Y. Imai et al. Nuclear receptors in bone physiology and diseases Physiol. Rev. 93 2 2013 481 523
16. Y. Merot et al. The relative contribution exerted by AF-1 and AF-2 transactivation functions in estrogen receptor alpha transcriptional activity depends upon the differentiation stage of the cell J. Biol. Chem. 279 25 2004 26184 26191
17. M.P. Kumar, L. Bhaskar, and R.V. Thampan Structural characterization of the goat uterine estrogen receptor activation factor using an endogenous calcium activated neutral protease Mol. Cell. Endocrinol. 152 1-2 1999 57 64 (Pubitemid 29305647)
18. S. Mader, P. Chambon, and J.H. White Defining a minimal estrogen receptor DNA binding domain Nucleic Acids Res. 21 5 1993 1125 1132 (Pubitemid 23155606)
19. J.M. Beekman et al. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain Mol. Endocrinol. 7 10 1993 1266 1274 (Pubitemid 23319109)
20. L.A. Paige et al. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta Proc. Nat. Acad. Sci. U.S.A. 96 7 1999 3999 4004 (Pubitemid 29169025)
21. B. Saville et al. Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements J. Biol. Chem. 275 8 2000 5379 5387 (Pubitemid 30115168)
22. M.T. Tzukerman et al. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions Mol. Endocrinol. 8 1 1994 21 30 (Pubitemid 24034253)
23. M. Jakacka et al. Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway J. Biol. Chem. 276 17 2001 13615 13621
24. P.J. Kushner et al. Estrogen receptor pathways to AP-1 J. Steroid Biochem. Mol. Biol. 74 5 2000 311 317 (Pubitemid 32126243)
25. S. Safe, and K. Kim Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways J. Mol. Endocrinol. 41 5 2008 263 275
26. J.S. Lewis, and V.C. Jordan Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance Mutat. Res. 591 1-2 2005 247 263 (Pubitemid 41654853)
27. L. Bjornstrom, and M. Sjoberg Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes Mol. Endocrinol. 19 4 2005 833 842 (Pubitemid 40397050)
28. E.R. Levin Cell localization: physiology, and nongenomic actions of estrogen receptors J. Appl. Physiol. 91 4 2001 1860 1867 (Pubitemid 32900382)
29. J. Mill et al. Association study of the estrogen receptor alpha gene (ESR1) and childhood-onset mood disorders Am. J. Med. Genet. B: Neuropsychiatr. Genet. 147B 7 2008 1323 1326
30. J. Wang et al. Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women Breast Cancer Res. Treat. 106 2 2007 273 280 (Pubitemid 350045020)
31. Y.K.et al. Chae Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer PLoS One 4 8 2009 e6523
32. Ensembl Ensembl Release 72 June 2013 Available from: http://www.ensembl. org/Homo-sapiens/Variation/Population?db=core;r=6:152128808-152129808;v= rs746432;vdb=variation;vf=600617, [cited 2013 August 30]
33. R. Metivier et al. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains Mol. Endocrinol. 15 11 2001 1953 1970 (Pubitemid 33026110)
34. S. Horjales et al. Translational machinery and protein folding: evidence of conformational variants of the estrogen receptor alpha Arch. Biochem. Biophys. 467 2 2007 139 143 (Pubitemid 350050888)
35. M. Berry, D. Metzger, and P. Chambon Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen EMBO J. 9 9 1990 2811 2818
36. J.D. Fan, B.L. Wagner, and D.P. McDonnell Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity Mol. Endocrinol. 10 12 1996 1605 1616 (Pubitemid 26408749)
37. P. Webb et al. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens Mol. Endocrinol. 9 4 1995 443 456
38. S. Solakidi, A.M. Psarra, and C.E. Sekeris Differential subcellular distribution of estrogen receptor isoforms: localization of ERalpha in the nucleoli and ERbeta in the mitochondria of human osteosarcoma SaOS-2 and hepatocarcinoma HepG2 cell lines Biochim. Biophys. Acta 1745 3 2005 382 392 (Pubitemid 41330791)
39. D.P. McDonnell et al. Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators Recent Prog. Horm. Res. 57 2002 295 316
40. A.L. Wijayaratne, and D.P. McDonnell The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators J. Biol. Chem. 276 38 2001 35684 35692
41. J.M. Hall, D.P. McDonnell, and K.S. Korach Allosteric regulation of estrogen receptor structure: function, and coactivator recruitment by different estrogen response elements Mol. Endocrinol. 16 3 2002 469 486 (Pubitemid 34214567)